ftil

 

FTIL: Govt examining NCLT order to decide next course of action

Jun 13 2018

The ruling pertained to a petition filed by the ministry seeking relief on various counts against the backdrop of the Rs 5,600-crore payment crisis at NSEL.

Sebi disposes of show-cause notice against ex-official of FTIL

May 02 2018

Sebi disposed of a show-cause notice against Hariharan Vaidyalingam, a former official of MCX, NSEL and FTIL, after charges of insider-trading could not be established.

Sebi disposes of show-cause notice against ex-NSEL,FTIL officials

Apr 27 2018

Sebi disposed of show-cause notices against 6 former officials of NSEL and FTIL in the MCX case.

Sebi disposes of cases against former NSEL official

Mar 13 2018

Sebi today disposed of two cases of alleged violation of insider trading norms against Shreekant Javalgekar and his wife Asha with regard to the shares of MCX and FTIL.

FTIL case: Sebi disposes of show cause notices against 5 persons

Feb 23 2018

Sebi disposed of show cause notices issued against five individuals in the matter of Financial Technologies, now known as 63 Moons Technologies.

Sebi diposes of show cause notices against 4 ex-MCX officials

Jan 30 2018

Sebi disposed of show cause notices against four former officials of MCX as alleged violation of insider trading rules by them could not be established.

HC junks FTIL's petition against govt order to merge with NSEL

Dec 04 2017

The Bombay HC dismissed a petition filed by the erstwhile FTIL challenging a 2016 decision of the Union govt ordering its merger with its subsidiary, NSEL.

Sebi to defreeze bank accounts of NSEL, MCX ex-chiefs

Aug 18 2017

Sebi will defreeze the bank accounts of Anjani Sinha and Joseph Massey which were frozen by the regulator in an alleged insider trading case.

NSEL scam: Sebi cracks down on former officials of MCX, FTIL

Aug 02 2017

Sebi impounded averted losses totalling Rs 125 crore through alleged insider trading in MCX and its erstwhile promoter FTIL by 13 persons.

NSEL urges Sebi to resolve Rs 5,600-cr payment crisis

Jul 31 2017

National Spot Exchange (NSEL) has urged Sebi to resolve the Rs 5,600-crore payment crisis in the larger interest of investors.

Indian Markets

 
  • SENSEX

    35,470.35 219.25   (-0.61 %)
  • NIFTY

    10,762.45 59.40   (-0.55 %)
sensex-box-shadowimg

Global Markets

 

Stocks In News

 

WHEELS INDIA

Mulls 1:1 Bonus Share Issue

CITY UNION BANK

To Issue 1:10 Bonus Shares; Record Date At July 11

AVANTI FEEDS

Approved Bonus Issue Of 1:2; Record Date At June 27

PHOENIX MILL

Arm Buys Under-Construction Asset For Rs 234 Cr In Indore At Auction

Brownfield Acquisition To Add Approx. 1.1 Mn Sq. Ft. To Co's Retail Portfolio

SYMPHONY

Co In Pact To Buy 95% Of Climate Tech Pty, Australia

Deal Size Stands At Rs 201-211 Cr In Valuation

TATA MOTORS

JLR Investor Presentation:

Have Exciting Products, Plans In The Pipeline To Generate Sustainable Growth

Aiming For A 4-7% EBIT Margin Over Medium Term, Will Invest 4.5 Bn GBP In FY19-21

Aiming For A 7-9% EBIT Margin Over Long Term

Long Term Investment Pegged At 12-13% Of Revenue

Retail Volume Grew By 1.7% & Revenue Grew By 6% In FY18

Also Launched Jaguar I-Pace As Co's First All Battery Electric Vehicle

ASIAN PAINTS

To Set Up 5 Lk KL/Annum Plant At Visakhapatnam For Rs 1,785 Cr

To Set Up 6 Lk KL/Annum Plant In Mysore For Rs 2,300 Cr

Co's International Business Did Not Perform Well In FY18

Economy & Inflated Currency Hit Co's Egyptian Operations

UNICHEM LAB

To Launch Generic Tadalafil After Filing ANDA With USFDA

BIOCON

Sterile Drug Product Manufacturing Facility In Bengaluru Receives EIR From USFDA

USFDA's Pre-Approval & Inspection Of Facility Done In April & May 2018

EIR Notifies That The Inspection Stands Closed

Co Committed To Global Standards Of Quality & Compliance

DR REDDY'S

Dr Reddy's Loses Patent Case With Eli Lilly Over Alimta

Co Cannot Launch Its Alternative Salt Forms Until The Eli Lilly Patent Expires

The U.S. District Court For The Southern District Of Indiana Ruled In Favour Of Lilly

The Eli Lilly Patent Expires In May 2022

twitter @BTVI